- Home
- ETON vs EIC Comparison
ETON vs EIC Comparison
Compare ETON & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- EIC
- Stock Information
- Founded
- ETON 2017
- EIC N/A
- Country
- ETON United States
- EIC United States
- Employees
- ETON N/A
- EIC N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- EIC Finance/Investors Services
- Sector
- ETON Health Care
- EIC Finance
- Exchange
- ETON Nasdaq
- EIC Nasdaq
- Market Cap
- ETON 329.8M
- EIC 287.1M
- IPO Year
- ETON 2018
- EIC 2019
- Fundamental
- Price
- ETON $14.41
- EIC $15.71
- Analyst Decision
- ETON Strong Buy
- EIC
- Analyst Count
- ETON 3
- EIC 0
- Target Price
- ETON $18.67
- EIC N/A
- AVG Volume (30 Days)
- ETON 243.0K
- EIC 116.0K
- Earning Date
- ETON 03-13-2025
- EIC 11-14-2023
- Dividend Yield
- ETON N/A
- EIC 13.63%
- EPS Growth
- ETON N/A
- EIC N/A
- EPS
- ETON N/A
- EIC 0.80
- Revenue
- ETON $34,677,000.00
- EIC N/A
- Revenue This Year
- ETON $22.25
- EIC N/A
- Revenue Next Year
- ETON $81.48
- EIC N/A
- P/E Ratio
- ETON N/A
- EIC $20.31
- Revenue Growth
- ETON 5.64
- EIC N/A
- 52 Week Low
- ETON $3.03
- EIC $13.00
- 52 Week High
- ETON $15.00
- EIC $16.48
- Technical
- Relative Strength Index (RSI)
- ETON 62.22
- EIC 48.32
- Support Level
- ETON $13.09
- EIC $15.76
- Resistance Level
- ETON $14.35
- EIC $15.93
- Average True Range (ATR)
- ETON 1.13
- EIC 0.20
- MACD
- ETON 0.08
- EIC 0.00
- Stochastic Oscillator
- ETON 82.60
- EIC 37.61
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.